๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

What do we know about the mechanism of action of disease-modifying treatments in MS?

โœ Scribed by Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos

Publisher
Springer
Year
2004
Tongue
English
Weight
481 KB
Volume
251
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

What do we know about the molecular mech
What do we know about the molecular mechanism of 3-MCPD ester formation?
โœ Anja Katerina Karin Rahn; Varoujan Antranik Yaylayan ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 192 KB ๐Ÿ‘ 2 views

## Abstract The 3โ€monochloropropaneโ€1,2โ€diol (3โ€MCPD) esters belong to a group of well known processโ€induced contaminants derived from monoโ€ and diโ€chlorinated glycerols. The 3โ€MCPD was first identified in 1978 in acidโ€hydrolysed vegetable proteins and its corresponding esters in 1980 and since the

What do we know about dementia?: a surve
What do we know about dementia?: a survey on knowledge about dementia in the general public of Japan
โœ Yumiko Arai; Asuna Arai; Steven H. Zarit ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

## Abstract ## Objective The importance of early detection of dementia has been highlighted in recent years by the medical and scientific community; however, delays often occur between the recognition of signs or symptoms and a decision by the patient or family to seek professional help. Such dela